These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 77724)

  • 1. Evaluation of the microleukocyte adherence inhibition assay as an immunodiagnostic test for pancreatic cancer.
    Russo AJ; Douglass HO; Leveson SH; Howell JH; Holyoke ED; Harvey SR; Chu TM; Goldrosen MH
    Cancer Res; 1978 Jul; 38(7):2023-9. PubMed ID: 77724
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of micro-leukocyte adherence inhibition as an immunodiagnostic test for pancreatic cancer.
    Goldrosen MH; Russo AJ; Howell JH; Leveson SH; Moore MC; Holyoke ED; Douglass HO
    Cancer Res; 1979 Feb; 39(2 Pt 2):633-7. PubMed ID: 367589
    [No Abstract]   [Full Text] [Related]  

  • 3. Demonstration of tube leukocyte adherence inhibition assay with coded samples of blood.
    Thomson DM
    Cancer Res; 1979 Feb; 39(2 Pt 2):627-9. PubMed ID: 83917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of the microtest version of the leukocyte adherence inhibition assay.
    Goldrosen MH; Howell JH; Holyoke ED
    Cancer Res; 1979 Feb; 39(2 Pt 2):630-2. PubMed ID: 367588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of leukocyte adherence inhibition in the immunodiagnosis of colorectal cancer.
    Halliday WJ; Maluish AE; Stephenson PM; Davis NC
    Cancer Res; 1977 Jul; 37(7 Pt 1):1962-71. PubMed ID: 67885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the leucocyte adherence inhibition assay in the diagnosis of colorectal carcinoma.
    Leveson SH; Woodhouse LF; Giles GR
    Clin Oncol; 1981 Sep; 7(3):183-91. PubMed ID: 7044636
    [No Abstract]   [Full Text] [Related]  

  • 7. Leukocyte adherence inhibition assay to detect primary cancer of the pancreas.
    Taguchi K
    Surg Forum; 1977; 28():123-5. PubMed ID: 364711
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of murine tumor-associated antigens by the micro-leukocyte adherence inhibition assay.
    Howell JH; Russo AJ; Goldrosen MH
    Cancer Res; 1979 Feb; 39(2 Pt 2):612-8. PubMed ID: 83914
    [No Abstract]   [Full Text] [Related]  

  • 9. [Leukocyte-adherence-inhibition reactivity in patients with colorectal and pancreatic cancer (author's transl)].
    Wagner T; Peschel U; Heydrich D; Ritter U
    Z Gastroenterol; 1981 Mar; 19(3):140-7. PubMed ID: 7234027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microplate leucocyte adherence inhibition (LAI) assay in pancreatic cancer: detection of specific antitumor immunity with patients' peripheral blood cells and serum.
    Goldrosen MH; Dasmahapatra K; Jenkins D; Howell JH; Arbuck SG; Moore MC; Douglass HO
    Cancer; 1981 Mar; 47(6 Suppl):1614-9. PubMed ID: 6168355
    [No Abstract]   [Full Text] [Related]  

  • 11. Early diagnosis of cancers of colon, pancreas, stomach, and lung by automated tube leukocyte adherence inhibition assay.
    Tataryn DN; MacFarlane JK; Thomson DM
    Surg Forum; 1978; 29():130-2. PubMed ID: 401404
    [No Abstract]   [Full Text] [Related]  

  • 12. [The L.A.I. test and tumor markers (Ca 19-9 and TPA) in the diagnosis of pancreatic carcinoma].
    Meduri F; Bizzarini M; Diana F; Merenda R; Gerunda GE; Doni MG; Maffei Faccioli A
    Minerva Chir; 1989 Aug; 44(15-16):1777-81. PubMed ID: 2682370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic detection of primary carcinoma of the pancreas.
    Taguchi K
    Can J Surg; 1978 Jul; 21(4):313-5. PubMed ID: 354762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 2. Preoperative studies and follow-up].
    Ludwig HJ; Storch H
    Zentralbl Gynakol; 1986; 108(10):607-19. PubMed ID: 3526756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunodiagnosis of gastrointestinal tumors with the leukocyte adherence inhibition test].
    Storch H; Stotz G; Liebe S; von Baehr R; Neumeister B
    Z Gesamte Inn Med; 1981 Jan; 36(2):suppl 223-4. PubMed ID: 7013295
    [No Abstract]   [Full Text] [Related]  

  • 16. Experiences with leukocyte adherence inhibition in human cancer.
    Maluish AE
    Cancer Res; 1979 Feb; 39(2 Pt 2):644-8. PubMed ID: 367590
    [No Abstract]   [Full Text] [Related]  

  • 17. The need to establish whether the leukocyte adherence inhibition test is a reliable assay of tumor immunity in humans.
    Hellström KE; Hellström I
    Cancer Res; 1979 Feb; 39(2 Pt 2):649-50. PubMed ID: 83919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral leukocyte adherence inhibition (H-LAI) with basic encephalitogenic protein (BEP) in head and neck cancer.
    Kövesi G; Fekete B
    Haematologia (Budap); 1985; 18(1):27-32. PubMed ID: 2581853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
    Ludwig HJ; Storch H
    Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The tumor-associated antigen CA 19-9 in the differential diagnosis and course control of malignancies of the pancreas and the gastrointestinal tract].
    Klapdor R; Greten H
    Dtsch Med Wochenschr; 1984 Dec; 109(50):1935-9. PubMed ID: 6210188
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.